Obesity in Pregnancy: Obstetrician' s Obstacle
1Bombay Hospital and Medical Research Centre, 12 New Marine Line, Mumbai, 400020 India.
Journal of Obstetrics and Gynaecology of India
|June 11, 2019
Summary
Managing obesity in pregnancy presents significant challenges for obstetricians due to increased risks for mothers and babies. This editorial offers practical tips for high-risk pregnancies involving maternal obesity.
Area of Science:
- Obstetrics and Gynecology
- Maternal-Fetal Medicine
- Bariatric Medicine
Background:
- Increasing incidence of overweight and obese women in reproductive age globally.
- Advances in bariatric medicine and surgery leading to more pregnancies in obese women.
- Pregnancy in obese women is considered high-risk due to adverse maternal and fetal outcomes.
Discussion:
- Challenges faced by obstetricians in managing pregnancies complicated by obesity.
- Need for well-equipped maternity units with multidisciplinary expert faculty.
- Practical management strategies and clinical tips for obstetric care.
Key Insights:
- Obesity in pregnancy necessitates specialized management protocols.
- Adverse maternal and fetal outcomes are significantly linked to maternal obesity.
- Multidisciplinary approach is crucial for optimizing care in high-risk pregnancies.
Outlook:
- Introduction of a new article format, "Invited Debate," discussing bariatric surgery pros and cons.
- Hope for improved clinical practice through shared expertise and evidence-based reviews.
- Future directions in managing obese pregnancies and improving outcomes.
Related Concept Videos
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:21Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...